Stanley Capital

Private Equity United Kingdom ·Founded 2019

Overview

Stanley Capital is an independent mid-market private equity firm that partners with management teams to create value through mergers and acquisitions, operational change, and technology enablement. Founded in 2019, the firm focuses on growing sustainable businesses in the Healthcare, Technology, and Resource Efficiency sectors across Europe and the United States. Stanley Capital targets companies with enterprise values ranging from $250 million to $2.5 billion. The firm's investment strategy involves a research and technology-driven approach to identify opportunities in the growing sustainable investment sectors of Resource Efficiency, Healthcare, and Technology. Stanley Capital partners with management teams in both majority and minority transactions to transform companies through growth via technology change, operational change, and market consolidation. The firm employs a system-wide approach, leveraging its specialist skillset in sector research, mergers and acquisitions, and digital transformation to find and unlock sustainable value for its portfolio. Since its inception, Stanley Capital has been actively involved in various investments and strategic partnerships. Notably, in January 2022, the firm formed a strategic partnership with Grafine Partners to invest in growing sustainable businesses. Additionally, Stanley Capital listed its first Special Purpose Acquisition Vehicle, Healthcare AI Acquisition Corp., on the NASDAQ under the ticker HAIA in December 2021. The firm continues to expand its portfolio and strengthen its team to support its growth and transformation initiatives.

Investment Focus

  • Sustainable business models
  • Growth potential
  • Alignment with firm's sectors of interest

Portfolio Companies

Grafine PartnersNoden PharmaSePRO CorporationRoboyoLaboratoire XOQinecsaDSSApplied Artificial Intelligence CorporationLXONimotop®My Meds and MeHAIA

Reach Stanley Capital directly

Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.

Unlock full contacts →

Frequently asked questions about Stanley Capital

What sectors does Stanley Capital invest in?

Stanley Capital invests in Technology, Healthcare and Resource Efficiency, and is based in United Kingdom. Stanley Capital is listed as a private equity in the ConnectSafely investor database.

What stage does Stanley Capital invest at?

Stanley Capital backs companies at Growth and Buyout, writing cheques of 250M - 2.5B.

Which regions does Stanley Capital invest in?

Stanley Capital invests across United States, United Kingdom, Germany, France, Italy and Denmark.

Who are the partners at Stanley Capital?

Team members listed for Stanley Capital include Amber Hilkene (Partner and Chief Growth Officer) and Simon Cottle (Founding Partner).

What companies has Stanley Capital invested in?

Stanley Capital's portfolio includes Grafine Partners, Noden Pharma, SePRO Corporation, Roboyo, Laboratoire XO, Qinecsa, DSS and Applied Artificial Intelligence Corporation.

How do I contact Stanley Capital?

Stanley Capital's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.

Last updated · Source: ConnectSafely investor database